Position in ABEO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,739,609
-$919,989 QoQ
Shares Held
611,520
-11.9% QoQ
Ownership
1.07%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABEO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Diametric Capital, LP holds $48,974,701 across 63 Biotechnology names. ABEO ranks #2 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PGEN |
Precigen, Inc.
|
6,801,788 | $26,322,919 | |
| 2 | ABEO |
Abeona Therapeutics Inc.
This page
|
611,520 | $2,739,609 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
63,896 | $2,079,175 | |
| 4 | SLNO |
Soleno Therapeutics Inc
|
57,832 | $1,936,215 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
15,000 | $1,458,750 | |
| 6 | ABVX |
Abivax S.A.
|
10,000 | $1,113,500 | |
| 7 | OCUL |
Ocular Therapeutix, Inc
|
125,000 | $1,058,750 | |
| 8 | ZVRA |
Zevra Therapeutics, Inc.
|
108,024 | $1,006,783 |
All Filings in ABEO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,739,609 | 611,520 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,659,598 | 694,421 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $914,501 | 173,201 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $785,901 | 138,363 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $89,269 | 18,754 | Shares | Defined | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||